The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

Sun Pharma is set to release its Q3 earnings on January 31, 2024, potentially declaring an interim dividend. The company reported a 28% increase in net profit to ₹3,040 crore for the September ...

Royalty Pharma (RPRX) announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its external manager, RP Management. This transaction to simplify ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

A Holbrook man is facing new charges after allegedly causing a fatal motor vehicle crash in Braintree while driving under the influence of alcohol, according to prosecutors. Ryan Gorman ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...

BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced ...

GORMAN IS ACCUSED OF DRIVING DRUNK AND CAUSING A HEAD ON COLLISION LAST MONTH ON UNION STREET IN BRAINTREE. 18 YEAR OLD ALEXIA NIXON, OF WEYMOUTH, WAS A PASSENGER IN THE SUV THAT GORMAN ALLEGEDLY ...

Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—reflecting ... with reputable sponsors, including leading global pharma companies.